Pricing Fit: The Hidden Reason Many IVD Products Fail in Asia

In Asia IVD, a product can have good technology, good performance and a capable manufacturer, yet still fail commercially. One of the most common reasons is not the product itself. It is poor pricing fit.

Many international IVD companies enter Asia assuming that a product price can be adjusted later after a distributor is appointed. In reality, pricing should be part of the market-entry strategy from the beginning. The right price is not simply a lower price. It is the price that fits the customer segment, testing volume, reimbursement environment, competitive alternatives, registration cost, distributor margin, service burden and long-term positioning of the product.

Asia is not one price market

Asia is often described as a high-growth IVD region, but this can be misleading if manufacturers treat it as one commercial block. A price that works in Singapore, Japan, South Korea or Hong Kong may not work in the Philippines, Indonesia, Vietnam, Sri Lanka, Bangladesh or secondary cities in larger markets.

Even within the same country, pricing expectations can differ sharply between government hospitals, private hospital groups, reference laboratories, regional laboratories, physician-owned clinics and tender-driven public accounts.

The distributor also needs room to breathe

A serious distributor may need to handle registration, warehousing, cold-chain management, demonstration units, tender participation, installation, training, application support, service calls, spare parts, congress activity and delayed customer payment.

If the manufacturer’s transfer price is too high, either the final customer price becomes uncompetitive or the distributor margin becomes too thin to support the product properly. Both outcomes are dangerous. A distributor with poor margin will naturally give more attention to easier and more profitable lines.

Premium positioning must be earned

Some IVD companies want premium pricing because their product is manufactured in Europe, the United States, Japan or another high-reputation market. Brand origin may help, but it is rarely enough by itself.

A premium price must be supported by a clear reason: better clinical value, stronger evidence, superior workflow, unique menu, better automation, lower repeat testing, stronger quality, faster turnaround time or meaningful labor savings.

Low pricing can also damage the business

Pricing fit does not always mean pricing lower. Underpricing can be just as damaging as overpricing. If a product is priced too low, the distributor may not be able to provide proper support and the manufacturer may not have enough margin to invest in training, documentation, marketing and regional management.

The right price depends on the intended segment

Before setting pricing, the manufacturer should decide which segment it wants to win: top-tier hospitals, national reference laboratories, mid-sized private labs, public tenders, regional hospitals, specialist clinics or emerging laboratories in secondary cities.

A good Asia pricing strategy should define the target customer first, then work backward to determine the viable customer price, distributor margin, registration investment, service model and manufacturer transfer price.

Pricing should be tested before launch

Before appointing a distributor or starting registration, manufacturers should test whether the pricing model is realistic. This can be done by comparing current alternatives, customer willingness to pay, expected test volume, competitive reagent pricing, analyzer placement model, payback period and distributor support cost.

The new reality

Asia remains one of the most important growth regions for IVD, but it is also becoming more competitive. Chinese suppliers are improving. Established brands are defending premium positions. Local distributors are becoming more selective. Laboratories are more cost-conscious and better informed.

In this environment, successful market entry requires more than good technology and a signed distribution agreement. It requires pricing fit.